Surgery to treat rectal cancer

Surgery to treat rectal cancer.

For many rectal cancer patients, the thought of surgery is a worrisome reality, given that the manoeuvring can significantly impair both bowel and sexual function. However, a supplementary study reveals that some cancer patients may fare just as well by forgoing surgery in favor of chemotherapy/radiation and "watchful waiting". The pronouncement is based on a review of data from 145 rectal cancer patients, all of whom had been diagnosed with echelon I, II or III disease All had chemotherapy and radiation.

But about half had surgery while the others staved off the practice in favor of rigorous tracking of their disease flow - sometimes called "watchful waiting liver health symptoms. We believe that our results will encourage more doctors to reflect this 'watch-and-wait' approach in patients with clinical complete response as an alternative to immediate rectal surgery, at least for some patients," older study author Dr Philip Paty said in a talk release from the American Society of Clinical Oncology (ASCO).

So "From my experience, most patients are eager to accept some risk to defer rectal surgery in hope of avoiding major surgery and preserving rectal function," said Paty, a surgical oncologist at the Memorial Sloan-Kettering Cancer Center in New York City. The findings are to be presented Monday at the Gastrointestinal Cancers Symposium in San Francisco. ASCO is one of four organizations sponsoring the symposium. Research presented at medical meetings should be viewed as antecedent until published in a peer-reviewed journal.

The boning up authors said that the sort of patients who would most proper do well without instant surgery are the up to 50 percent of stage I patients whose tumors typically evanesce altogether following initial chemotherapy/radiation treatment. That figure hovers at between 30 percent and 40 percent amid stage II and III patients. The original investigation looked at the experience of rectal cancer patients who were treated between 2006 and 2014 at Memorial Sloan-Kettering.

While all the patients had savvy complete tumor regression following chemotherapy/radiation, only some underwent spontaneous rectal surgery. The other 73 patients were instead followed with "watchful waiting," which involved reinforcement exams every few months. Ultimately, nearly three-quarters of the non-surgery group remained cancer-free approximately four years later, while about one area had to undergo surgery to treat tumor recurrence supplement. Overall, the four-year survival merit was 91 percent in the no-surgery group vs 95 percent in the surgery group.

tag : surgery patients rectal cancer percent radiation chemotherapy group waiting

Post a comment

Private comment



Dr. Alejandra Falto

Новые записи
Новые комментарии
Новые трэкбэки
Архив по месяцам
Форма поиска
RSS ссылка
Формуляр приглашения в блог-друзья

Добавить автора в блог-друзья